The inflammatory process and oxidative stress downstream of dystrophin deficiency contribute to muscle pathology in DMD, with documented NF-κB activation inducing the expression of several inflammatory mediators. The gene discussed is NFKB1; the disease is Duchenne muscular dystrophy.